Incidence and determinants of migraine prophylactic medication in the Netherlands.
about
Prophylactic treatment of migraine by GPs: a qualitative study.Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study.Triptan use in Australia 1997-2015: A pharmacoepidemiological study.Migraine prophylactic medication usage patterns in The Netherlands.Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.Reducing the burden of headache: The International Headache Society Primary Care Interest Group.
P2860
Incidence and determinants of migraine prophylactic medication in the Netherlands.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Incidence and determinants of migraine prophylactic medication in the Netherlands.
@en
type
label
Incidence and determinants of migraine prophylactic medication in the Netherlands.
@en
prefLabel
Incidence and determinants of migraine prophylactic medication in the Netherlands.
@en
P2093
P1476
Incidence and determinants of migraine prophylactic medication in the Netherlands.
@en
P2093
Egberts AC
Leufkens HG
Rahimtoola H
Tijssen CC
P2888
P304
P356
10.1007/S00228-002-0443-8
P577
2002-04-05T00:00:00Z